| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 07/31/2007 | US7250494 Opsonic monoclonal and chimeric antibodies specific for lipoteichoic acid of Gram positive bacteria |
| 07/31/2007 | US7250493 FC fusion proteins of human erythropoietin with increased biological activities |
| 07/31/2007 | US7250492 Compositions and methods for inhibition of cancer invasion and angiogenesis |
| 07/31/2007 | US7250488 Transcriptional activation inhibitory protein |
| 07/31/2007 | US7250405 Modified pituitary gland development in offspring from expectant mother animals treated with growth hormone releasing hormone therapy |
| 07/31/2007 | US7250400 Can be used for developing a study of cell attachment activity mediated through various extracellular matrix protein containing beta ig-h3, wound healing, tissue regeneration and metastasis inhibition. |
| 07/31/2007 | US7250298 Monomeric red fluorescent proteins |
| 07/31/2007 | US7250285 Isolated nucleic acid; screening for antibacterial compounds |
| 07/31/2007 | US7250283 Nucleotide sequences coding polypeptide associate with fatty acid metabolism for use in diagnosis, prevention and treatment of obesity, diabetes and heart disease |
| 07/31/2007 | US7250278 α-keto acid reductase, method for producing the same, and method for producing optically active α-hydroxy acids using the same |
| 07/31/2007 | US7250275 LIF has a differentiation prevention function for a chicken differentiable cell such as a chicken's embryonic stem cell or embryonic reproductive cell, effective as an anti-differentiator while the chicken differentiable cell is being cultured |
| 07/31/2007 | US7250274 IL-21 production in prokaryotic hosts |
| 07/31/2007 | US7250273 Human peroxisome proliferator activated receptor γ: compositions and methods |
| 07/31/2007 | US7250271 Anti-angiogenesis methods, compositions and uses therefor |
| 07/31/2007 | US7250268 Providing a cell which expresses an a fusion protein, contacting said cell with a test compound; determining whether test compound inhibits I kappa B kinase (IKK) activity |
| 07/31/2007 | US7250172 Vaccine and compositions for the prevention and treatment of neisserial infections |
| 07/31/2007 | US7250168 Oxidative damage and protease activity resistance; catalytic efficiency; deep vein thrombosis, disseminated intravascular coagulation, acute coronary syndrome |
| 07/31/2007 | US7250165 Anti-TNF antibodies, compositions, methods and uses |
| 07/31/2007 | CA2331936C Proteins with changed epitopes and methods for the production thereof |
| 07/31/2007 | CA2085469C Water-soluble polypeptides with strong affinity for .alpha. and .beta. interferons |
| 07/31/2007 | CA1341537C Production of pluripotent granulocyte colony-stimulating factor |
| 07/26/2007 | WO2007084715A2 Tat-031 and methods of assessing and treating cancer |
| 07/26/2007 | WO2007084527A2 Proteins containing a fluorinated amino acid, and methods of using same |
| 07/26/2007 | WO2007083644A1 Novel protein expression system |
| 07/26/2007 | WO2007083175A1 Antiviral bifunctional molecules, methods of construction and methods of treating virus-induced cancer therewith |
| 07/26/2007 | WO2006113743A3 Compositions and methods for rna interference with sialidase expression and uses thereof |
| 07/26/2007 | WO2004003175A3 Process and materials for production of glucosamine and n-acetylglucosamine |
| 07/26/2007 | WO2003053220A3 Compositions and methods for the therapy and diagnosis of inflammatory bowel disease |
| 07/26/2007 | WO2003023010A3 Sensory neuron receptors |
| 07/26/2007 | WO2002038600A9 C. elegans genes involved in viability and/or reproduction and uses thereof |
| 07/26/2007 | US20070174926 Sperm factor oscillogenin |
| 07/26/2007 | US20070174922 Nucleic acid encoding novel type-1 cytokine receptor glm-r |
| 07/26/2007 | US20070173477 Polypeptides and nucleic acid molecules encoding the polypeptide; such molecules have use as probes for diagnosis of Alzheimer's disease, and for identification of compounds that modulate the activity of beta secretase |
| 07/26/2007 | US20070173443 polypeptides that induce apoptosis of cancer cells that contain mutant p53 or over-expressed wild-type p53 |
| 07/26/2007 | US20070173441 Inhibitors of n ethymalemide sensitive factor |
| 07/26/2007 | US20070173431 Novel variant hypocrea jercorina CBH1 cellulases |
| 07/26/2007 | US20070172928 Immunoglobulin chimeric monomer-dimer hybrids |
| 07/26/2007 | US20070172927 Immune complexes comprising proteins of human immunodeficiency virus type 2 (HIV-2), antibodies against proteins of HIV-2, methods and kits employing proteins of HIV-2, and immunogenic compositions comprising proteins of HIV-2 |
| 07/26/2007 | US20070172924 Increasing the stability of recombinant adult human apohemoglobin |
| 07/26/2007 | US20070172923 Homogeneous preparations of il-28 and il-29 |
| 07/26/2007 | US20070172922 Secretion, transcription and sporulation genes in Bacillus clausii |
| 07/26/2007 | US20070172921 Secretion, transcription and sporulation genes in Bacillus clausii |
| 07/26/2007 | US20070172920 Immunoconjugates and humanized antibodies specific for b-cell lymphoma and leukemia cells |
| 07/26/2007 | US20070172919 WDR36 Gene Alterations and Glaucoma |
| 07/26/2007 | US20070172918 Non aggregating fluorescent proteins and methods for using the same |
| 07/26/2007 | US20070172917 Cytokine receptor zalpha11 |
| 07/26/2007 | US20070172916 Novel bacillus 029cel cellulase |
| 07/26/2007 | US20070172915 Glycoprotein synthesis |
| 07/26/2007 | US20070172914 Protein concentrate and an aqueous stream containing water-soluble carbohydrates |
| 07/26/2007 | US20070172909 Non-ribosomal peptide synthetases and associated biosynthetic genes |
| 07/26/2007 | US20070172892 Novel polypeptide esdn, polynucleotides encoding the polypeptide, and utility of the polypeptide |
| 07/26/2007 | US20070172882 Identification of a family of secreted proteins in vascular endothelium |
| 07/26/2007 | US20070172881 Expression vector comprising fungal gene sequences for use as tool in identifying antifungal polypeptides for use in treatment and prevention of fungal infection |
| 07/26/2007 | US20070172880 Transient Receptor Potential Channels is an emerging class of Ca2+-permeable cation channel superfamily; for diagnosis, treatment, and/or prevention of various diseases |
| 07/26/2007 | US20070172861 Mutant polymerases |
| 07/26/2007 | US20070172850 Novel chromophores/fluorophores and methods for using the same |
| 07/26/2007 | US20070172849 Detection of markers in nascent proteins |
| 07/26/2007 | US20070172830 Antibodies to hhpen62 polypeptide |
| 07/26/2007 | US20070172825 Methods and kits for identifying functions and binding substances of gene products |
| 07/26/2007 | US20070172579 Protein hydrolysates and method of making |
| 07/26/2007 | US20070172544 Method of quickly measuring factor causing early flocculation of yeast |
| 07/26/2007 | US20070172495 Lactobacillus acidophilus nucleic acid sequences encoding cell surface protein homologues and uses therefore |
| 07/26/2007 | US20070172487 Alpha-enolase specific antibody and method of use |
| 07/26/2007 | US20070172485 Glycopeptides derived from pancreatic structures, antibodies and applications thereof in diagnostics and therapeutics |
| 07/26/2007 | US20070172480 Recombinant platelet collagen receptor glycoprotein vi and its pharmaceutical use |
| 07/26/2007 | US20070172470 Phosphatase regulation of nucleic acid transcription |
| 07/26/2007 | US20070172459 modified interferons for use in the treatment and prevention of viral infections, cell proliferative and autoimmune disorders |
| 07/26/2007 | US20070172458 IL-6/IL-6R fusion protein |
| 07/26/2007 | US20070172457 Interleukins-21 and 22 |
| 07/26/2007 | US20070172456 IL-1 zeta, IL-1 zeta splice variants and Xrec2 DNAs and polypeptides |
| 07/26/2007 | US20070172455 Chimeric Interleukin-6 Soluble Receptor/Ligand Protein, Analogs Thereof and Uses Thereof |
| 07/26/2007 | US20070172446 Synthetic chemokine receptor ligands and methods of use thereof |
| 07/26/2007 | CA2637730A1 Soluble fragments of the sars-cov spike glycoprotein |
| 07/26/2007 | CA2637254A1 Compositions and methods for humanization and optimization of n-glycans in plants |
| 07/26/2007 | CA2637252A1 Plants and plant cells having inhibited expression of .alpha.1,3-fucosyltransferase and .beta.1,2-xylosyltransferase |
| 07/26/2007 | CA2636600A1 Novel protein expression system |
| 07/25/2007 | EP1811035A1 Aspartic proteinase 2 (ASP2) |
| 07/25/2007 | EP1811033A1 Cell-permeable peptide inhibitors of the JNK signal transduction pathway |
| 07/25/2007 | EP1811031A1 Method for selecting a peptide or polypeptide which binds to a target molecule |
| 07/25/2007 | EP1811027A1 Polynucleotide for production of recombinant protein by silkworm |
| 07/25/2007 | EP1811026A1 Method of immunizing animal, composition for immunization, method of producing antibody, method of producing hybridoma and method of producing monoclonal antibody |
| 07/25/2007 | EP1811023A1 Gene expressed specifically in es cells and utilization of the same |
| 07/25/2007 | EP1811020A1 Escherichia coli phytase |
| 07/25/2007 | EP1810980A1 Interleukin-6 inhibitors |
| 07/25/2007 | EP1810979A1 STABILIZED HUMAN IgG4 ANTIBODIES |
| 07/25/2007 | EP1810001A2 An apparatus for and method of sampling and collecting powders flowing in a gas stream |
| 07/25/2007 | EP1809761A2 Compositions and methods for modulating dhr96 |
| 07/25/2007 | EP1809758A2 In vivo site-specific incorporation of n-acetyl-galactosamine amino acids in eubacteria |
| 07/25/2007 | EP1809741A1 Endo-n-acetyl-beta-d-glucosaminidase enzymes of filamentous fungi |
| 07/25/2007 | EP1809670A2 Irta-4 antibodies and their uses |
| 07/25/2007 | EP1649025A4 Methods of decoupling reaction scale and protein synthesis yield in batch mode |
| 07/25/2007 | EP1575998A4 Mammalian cell culture processes for protein production |
| 07/25/2007 | EP1436379B1 Dna fpr expression of alpha i-antitrypsin in methylotropic yeast |
| 07/25/2007 | EP1350105B1 Immunoassays for anti-hcv antibodies |
| 07/25/2007 | EP1287144B1 Bacterial insecticidal proteins |
| 07/25/2007 | EP1148129B1 Betacellulin modification |
| 07/25/2007 | EP1111052B1 Lysozyme-sensitive C. glutamicum |
| 07/25/2007 | EP0824546B1 Angiostatin fragments and methods of use |
| 07/25/2007 | EP0698092B1 Antisense oligonucleotides which combat aberrant splicing and methods of using the same |
| 07/25/2007 | EP0676965B1 Method of reducing immunogenicity of variable region of antibodies |